BWXT — BWX Technologies, Inc.

BWXT Q4 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Q4 Revenue: $886 million, up 19% year-over-year.
• Full Year Revenue: Grew 18% to approximately $3.2 billion.
• Adjusted EBITDA: $148 million for Q4, up 13% year-over-year; full year adjusted EBITDA grew 15%.
• Earnings Per Share (EPS): $1.08 for Q4, up 17%; full year EPS grew 20%.
• Free Cash Flow: $57 million in Q4; $295 million for the full year, up 16%.
• Backlog: Ended 2025 at $7.3 billion, up 50% year-over-year.

2. Strategic Updates and Business Highlights

• Acquisitions: Completed acquisitions of AOT and Kinectrics, enhancing capabilities and securing significant contracts.
• Government Operations: New pricing agreements for naval propulsion and contracts for uranium enrichment capabilities.
• Commercial Operations: Notable 31% organic revenue growth in Q4, with total revenue growth of 95% driven by nuclear power and medical sectors.
• Facilities Investment: Opened BWST Innovation Campus and Centrifuge manufacturing facility; ongoing expansion at the Cambridge plant.
• Technological Advancements: Progress in AI initiatives and digital transformation, including the establishment of the BWXT Digital Center.

3. Forward Guidance and Outlook

• 2026 Revenue Guidance: Expected to be approximately $3.75 billion, representing high teens growth compared to 2025.
• Adjusted EBITDA Guidance: Projected between $645 million to $660 million, indicating low to mid-teens growth.
• EPS Guidance: Expected to be between $4.55 to $4.70, up mid- to high teens.
• Free Cash Flow Guidance: Anticipated to be $305 million to $320 million, supporting reinvestment and shareholder value.

4. Bad News, Challenges, or Points of Concern

• Government Operations Decline: Revenue down 1% in Q4, with adjusted EBITDA down 5%, attributed to lower volumes and long lead material procurement.
• Margins Pressure: Anticipated lower margins in Government Operations due to new program ramp-ups and initial investment costs.
• Regulatory Risks: Ongoing investigation by the Canadian Competition Bureau regarding the Kinectrics acquisition remains unresolved.
• Tech 99 Approval Delays: No revenue from Tech 99 anticipated in 2026 due to unresolved product quality issues.

5. Notable Q&A Insights

• Government Operations Margins: CFO Mike Fitzgerald indicated no expected incremental pressure on margins in 2027, with a rebound anticipated.
• AI Utilization: CEO Rex Geveden discussed the phased approach to AI integration, focusing on manufacturing process improvements and future automation.
• Supply Chain Improvements: Positive developments in shipyard operations noted, with expectations for improved delivery rates.
• M&A Strategy: BWXT remains open to M&A opportunities, particularly those that enhance core capabilities and capacity.
• AP1000 and CANDU Contracts: Competitive positioning for future contracts discussed, with optimism for both North American and European projects.

Overall, BWXT reported strong financial performance in 2025, driven by robust demand across its nuclear markets, while also highlighting strategic growth initiatives and addressing potential challenges ahead.